Jul 14, 2023, 18:15
Meta-analysis on the prognostic value of HER2-low in breast cancer – Guilherme Nader Marta
Now out in ESMO Open our meta-analysis led by chiara molinelli on the prognostic value of HER2-low in breast cancer including data from ~1.8 million patients!
HER2-low showed slightly better outcomes and the interaction with ER/PR appears to be relevant.
For article: Click here